Glyoxalase i and aldose reductase gene polymorphisms and susceptibility to carotid atherosclerosis in type 2 diabetes

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 4, 2011, Pages 273-279

  Wu, Jing Cheng ^a   Li, Xiao Hua ^a   Wang, Jian Bo ^a   Tang, Jian Feng ^a   Wang, Yu Fei ^a   Peng, Yong De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; LACTOYLGLUTATHIONE LYASE;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETIC PATIENT; DNA POLYMORPHISM; ECHOGRAPHY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREVALENCE;

AGED; ALDEHYDE REDUCTASE; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERY DISEASES; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 79953093758     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0075     Document Type: Article

References (37)

1. Ahmed U, Dobler D, Larkin SJ, et al. (2008) Reversal of hyperglycemia-induced angiogenesis deficit of human endothelial cells by overexpression of glyoxalase 1 in vitro. Ann N Y Acad Sci 1126:262-264. (Pubitemid 351589297)
2. Baba SP, Barski OA, Ahmed Y, et al. (2009) Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue. Diabetes 58:2486-2497.
3. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820. (Pubitemid 34000785)
4. Chang KC, Paek KS, Kim HJ, et al. (2002) Substrate-induced upregulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 61:1184-1191. (Pubitemid 34441784)
5. Chang T, Wang R, Wu L (2005) Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radic Biol Med 38:286-293. (Pubitemid 39656138)
6. Degaffe GH, Vander Jagt DL, Bobelu A, et al. (2008) Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project. J Diabetes Complications 22:267-272. (Pubitemid 351885490)
7. Engelen L, Ferreira I, Brouwers O, et al. (2009) Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. J Hypertens 27:1 399-1403.
8. Gale CP, Futers TS, Summers LK (2004) Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors. Diabetes Vasc Dis Res 1:34-39.
9. Goldin A, Beckman JA, Schmidt AM, et al. (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597-605. (Pubitemid 44199649)
10. Greene DA, Lattimer SA, Sima AA (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606. (Pubitemid 17024483)
11. Hollander M, Bots ML, Del Sol AI, et al. (2002) Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 105:2872-2877. (Pubitemid 34666101)
12. Huebschmann AG, Regensteiner JG, Vlassara H, et al. (2006) Diabetes and advanced glycoxidation end products. Diabetes Care 29:1420-1432. (Pubitemid 44125953)
13. Humphries SE, Morgan L (2004) Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 3:227-235. (Pubitemid 38373661)
14. Junaid MA, Kowal D, Barua M, et al. (2004) Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A 131:11-17. (Pubitemid 39434789)
15. Kageyama R, Pastan I (1989) Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell 59:815-825. (Pubitemid 20022372)
16. Kaiserova K, Tang XL, Srivastava S, et al. (2008) Role of nitric oxide in regulating aldose reductase activation in the ischemic heart. J Biol Chem 283:9101-9112.
17. Kalousová M, Germanová A, Jáchymová M, et al. (2008) A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patient. Ann N y Acad Sci 1126:268-271. (Pubitemid 351589274)
18. Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120-126. (Pubitemid 9238733)
19. Kilhovd BK, Berg TJ, Birkeland KI, et al. (1999) Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 22:1543-1548. (Pubitemid 29418253)
20. Kirk RL, Ranford PR, Serjeantson SW, et al. (1985) HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics. Diabetes Res Clin Pract 1:41-47. (Pubitemid 16073182)
21. Kumagai T, Nangaku M, Kojima I, et al. (2009) Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 296: F912-F921.
22. Lusis AJ, Fogelman AM, Fonarow GC (2004) Genetic basis of atherosclerosis: part II: clinical implications. Circulation 110:2066-2071. (Pubitemid 39331923)
23. Mansia G, De Backer G, Dominiczak A, et al. (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105-1187. (Pubitemid 46924065)
24. Mimura G, Kida K, Matsuura N, et al. (1990) Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies-the J. D. S. study. Diabetes Res Clin Pract 8:253-262. (Pubitemid 20111450)
25. Miyata T, van Ypersele de Strihou C, Imasawa T, et al. (2001) Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney Int 60:2351-2359. (Pubitemid 33070479)
26. Nabel EG (2003) Cardiovascular disease. N Engl J Med 349:60-72. (Pubitemid 36765105)
27. O'Leary DH, Polak JF, Kronmal RA, et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22. (Pubitemid 29024679)
28. Price CL, Knight SC (2009) Methylglyoxal: possible link between hyperglycaemia and immune suppression? Trends Endocrinol Metab 20:312-317.
29. Salonen JT, Salonen R (1991) Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 11:1245-1249.
30. Shi YY, He L (2003) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97-98. (Pubitemid 41653949)
31. Shinmura K, Bolli R, Liu SQ, et al. (2002) Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res 91:240-246. (Pubitemid 34875679)
32. Shinohara M, Thornalley PJ, Giardino I, et al. (1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101:1142-1147. (Pubitemid 28125293)
33. So WY, Wang Y, Ng MC, et al. (2008) Aldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1, 074 type 2 diabetic patients. Diabetes Care 31:2148-2153.
34. Wang Y, Ng MC, Lee SC, et al. (2003) Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care 26:2410-2415. (Pubitemid 36993335)
35. Wolff B, Braun C, Schlü ter C, et al. (2005) Endothelial nitric oxide synthase Glu (298) →Asp polymorphism, carotid atherosclerosis and intima-media thickness in a general population sample. Clin Sci (Lond) 109:475-481. (Pubitemid 41640629)
36. Yamasaki Y, Katakami N, Sakamoto K, et al. (2006) Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care 29:2445-2451. (Pubitemid 44912250)
37. Yang B, Millward A, Demaine A (2003) Functional differences between the susceptibility Z-2/C-106 and protective Z+2/T-106 promoter region polymorphisms of the aldose reductase gene may account for the association with diabetic microvascular complications. Biochim Biophys Acta 1639:1-7. (Pubitemid 37013344)